Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Export
Sort by: Relevance
  • Open Access Icon
  • Research Article
  • 10.1177/10742484261428559
Eleutheroside E Attenuates Doxorubicin-Induced Cardiotoxicity by Suppressing Ferroptosis Through Activation of the Nrf2/SLC7A11/GPX4 Signaling Pathway.
  • Mar 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Peng Sun + 11 more

  • Open Access Icon
  • Research Article
  • 10.1177/10742484261428536
Preliminary Evidence for the Association of APOB rs1042034 With Short-Term Statin-Induced Lipid Lowering: An Exploratory Study in Vietnam.
  • Mar 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Chau Thi Kim Doan + 11 more

  • Research Article
  • 10.1177/10742484261431512
Factors Associated With the Selection of Anti-Hypertensive Medications: A Retrospective Cross-Sectional Analysis.
  • Mar 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Aymen Alqurain + 17 more

  • Open Access Icon
  • Research Article
  • 10.1177/10742484261433147
Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study.
  • Mar 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Fawaz H Tawhari + 12 more

  • Front Matter
  • 10.1177/10742484261436224
Bringing Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) to a Next Level: Strategies and Vision to Ensure a Sustained Journal Growth.
  • Mar 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Josip Andelo Borovac

  • Research Article
  • 10.1177/10742484261431652
Factors Associated With Loop Diuretic De-escalation in Patients With Acute Decompensated Heart Failure: The Influence of Guideline Directed Medical Therapy Initiation.
  • Feb 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Satoshi Hanazawa + 7 more

  • Research Article
  • 10.1177/10742484261440340
Optimal Switching Antiplatelet Regimen in Patients with Ticagrelor to a Thienopyridine in Korean Patients (SWAPT-K Study).
  • Feb 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Hyoun-Woo Noh + 13 more

  • Research Article
  • 10.1177/10742484261440344
Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction.
  • Feb 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Didi Yuan + 6 more

  • Front Matter
  • 10.1177/10742484261440329
From Indirect Evidence to Head-to-Head Trials in Anticoagulation: Clinical Implications of the COBRRA Moment in DOAC Treatment.
  • Feb 1, 2026
  • Journal of cardiovascular pharmacology and therapeutics
  • Andrej Belancic + 1 more

  • Open Access Icon
  • Research Article
  • 10.1177/10742484251351120
Knockdown of CXCL13 Improves Vascular Remodeling, Reduces Blood Pressure and Protects the Heart in a Hypertensive rat Model by Regulating the PF4V1/NF-κB Signaling Pathway.
  • Sep 1, 2025
  • Journal of cardiovascular pharmacology and therapeutics
  • Jie Ma + 2 more